Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous infusion of remimazolam in PFNA surgery for elderly patients
ChiCTR2500106656Phase 4Recruiting
- Sponsor
- Zigong Fourth People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in intertrochanteric fracture (2 arms), sponsored by Zigong Fourth People's Hospital. Primary endpoint: Blood pressure. Started Jul 2025; status: recruiting.
02
Drugs
remimazolam
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on ChiCTR2500106656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106656.